Final answer:
Chronic myelogenous leukemia is a myeloid malignancy while acute lymphoblastic leukemia is a lymphoid malignancy, meaning one affects myeloid cells and the other affects lymphocytes. Both conditions result in an abnormal production of leukocytes, compromising the body's blood cell production and immune function. Thus, the correct answer is: c) One is myeloid, and the other is lymphoid.
Step-by-step explanation:
Chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) are two types of leukemia, which is a cancer of the blood or bone marrow characterized by abnormal production of blood cells. CML is a myeloid malignancy, where mature leukocytes accumulate and fail to die. On the other hand, ALL is a lymphoid malignancy involving an overproduction of immature leukocytes or lymphocytes. Thus, the correct answer is: c) One is myeloid, and the other is lymphoid.
Leukemia undermines the body's ability to produce healthy blood cells, including erythrocytes, lymphocytes, and platelets, as abnormal cells crowd out healthy cells within the bone marrow. This can lead to impaired immune function, increased bleeding risk, and other health complications. Treatments for leukemia are tailored to the specific type of cancer and its progression. Thus, the correct answer is: c) One is myeloid, and the other is lymphoid.